Thomas Fischer

63PUBLICATIONS
347CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Sep 18, 2026
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

|Jun 21, 2026
The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO).

|Jun 21, 2026
Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025.

|Jun 11, 2026
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.

|Jun 03, 2026
Type-I interferon-activated NK cells control polycythemia vera in vivo.

|May 23, 2026
Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP).

Pageof 11

Frequent Collaborators

7 joint publications

Francesca Palandri

6 joint publications

Steffen Koschmieder

5 joint publications

Massimo Breccia

5 joint publications

Andreas Hochhaus